On the one hand, more than one study illustrated that CRP in peripheral blood, as well as soluble triggering receptor expressed on myeloid cells 2 (sTREM2), central nervous system specific protein beta (S100β) and YKL-40 in CSF, exhibited good diagnostic accuracy in distinguishing PD patients from controls. This evidence concerns the gene CHI3L1 and Parkinson disease.